Validity of the modified Rankin Scale in patients with aneurysmal subarachnoid hemorrhage: a randomized study

Autor: E. Nobels-Janssen, E. N. Postma, I. L. Abma, J. M. C. van Dijk, I. R. de Ridder, H. Schenck, W. A. Moojen, M. H. den Hertog, D. Nanda, A. R. E. Potgieser, B. A. Coert, W. I. M. Verhagen, R. H. M. A. Bartels, P. J. van der Wees, D. Verbaan, H. D. Boogaarts

Publikováno v: BMC Neurology, Vol 24, Iss 1, Pp 1-11 (2024)

Abstract Purpose The modified Rankin Scale (mRS), a clinician-reported outcome measure of global disability, has never been validated in patients with aneurysmal subarachnoid hemorrhage (aSAH). The aims of this study are to assess: (1) convergent val

Externí odkaz: https://doaj.org/article/75cc909570b4451a90e9060315e284f3

MR CLEAN-LATE, a multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in The Netherlands for late arrivals: study protocol for a randomized controlled trial

Autor: F. A. V. ( Anne) Pirson, Wouter H. Hinsenveld, Robert-Jan B. Goldhoorn, Julie Staals, Inger R. de Ridder, Wim H. van Zwam, Marianne A. A. van Walderveen, Geert J. Lycklama à Nijeholt, Maarten Uyttenboogaart, Wouter J. Schonewille, Aad van der Lugt, Diederik W. J. Dippel, Yvo B. W. E. M. Roos, Charles B. L. M. Majoie, Robert J. van Oostenbrugge, on behalf of the MR CLEAN-LATE investigators

Publikováno v: Trials, Vol 22, Iss 1, Pp 1-13 (2021)

Abstract Background Endovascular therapy (EVT) for acute ischemic stroke due to proximal occlusion of the anterior intracranial circulation, started within 6 h from symptom onset, has been proven safe and effective. Recently, EVT has been proven effe

Externí odkaz: https://doaj.org/article/d6f912a1a7254147bf370d31fe3a16bf

Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate

Autor: Paul Reddell, Thomas R. De Ridder, John M. Morton, Pamela D. Jones, Justine E. Campbell, Graham Brown, Chad M. Johannes, Peter F. Schmidt, Victoria Gordon

Publikováno v: Journal of Veterinary Internal Medicine, Vol 35, Iss 1, Pp 430-441 (2021)

Abstract Background Tigilanol tiglate (TT) is a novel small molecule for intratumoral treatment of nonmetastatic mast cell tumors (MCTs) in dogs. In a randomized controlled clinical study, 75% of dogs that received a single TT treatment achieved comp

Externí odkaz: https://doaj.org/article/ce30c3d533e44be39a8c2c5a3b666f9e

Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands

Autor: Susanne G H Olthuis, F Anne V Pirson, Florentina M E Pinckaers, Wouter H Hinsenveld, Daan Nieboer, Angelique Ceulemans, Robrecht R M M Knapen, M M Quirien Robbe, Olvert A Berkhemer, Marianne A A van Walderveen, Geert J Lycklama à Nijeholt, Maarten Uyttenboogaart, Wouter J Schonewille, P Matthijs van der Sluijs, Lennard Wolff, Henk van Voorst, Alida A Postma, Stefan D Roosendaal, Anouk van der Hoorn, Bart J Emmer, Menno G M Krietemeijer, Pieter-Jan van Doormaal, Bob Roozenbeek, Robert-Jan B Goldhoorn, Julie Staals, Inger R de Ridder, Christiaan van der Leij, Jonathan M Coutinho, H Bart van der Worp, Rob T H Lo, Reinoud P H Bokkers, Ewoud I van Dijk, Hieronymus D Boogaarts, Marieke J H Wermer, Adriaan C G M van Es, Julia H van Tuijl, Hans G J Kortman, Rob A R Gons, Lonneke S F Yo, Jan-Albert Vos, Karlijn F de Laat, Lukas C van Dijk, Ido R van den Wijngaard, Jeannette Hofmeijer, Jasper M Martens, Paul J A M Brouwers, Tomas Bulut, Michel J M Remmers, Thijs E A M de Jong, Heleen M den Hertog, Boudewijn A A M van Hasselt, Anouk D Rozeman, Otto E H Elgersma, Bas van der Veen, Davy R Sudiono, Hester F Lingsma, Yvo B W E M Roos, Charles B L M Majoie, Aad van der Lugt, Diederik W J Dippel, Wim H van Zwam, Robert J van Oostenbrugge

Publikováno v: The Lancet (London), 401, 10385, pp. 1371-1380
The Lancet, 401(10385), 1371-1380. Elsevier Limited
The Lancet, 401(10385), 1371-1380. Elsevier Ltd.
The Lancet, 401(10385), 1371-1380. ELSEVIER SCIENCE INC
The Lancet (London), 401, 1371-1380
MR CLEAN-LATE investigators 2023, ' Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands : a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial ', The Lancet, vol. 401, no. 10385, pp. 1371-1380 . https://doi.org/10.1016/S0140-6736(23)00575-5
Lancet, 401(10385), 1371-1380. Elsevier Science

BACKGROUND: Endovascular treatment for anterior circulation ischaemic stroke is effective and safe within a 6 h window. MR CLEAN-LATE aimed to assess efficacy and safety of endovascular treatment for patients treated in the late window (6-24 h from s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a46cfb9f76a2c972c8a03f6874d3840
https://doi.org/10.1016/s0140-6736(23)00575-5

Influence of the interventionist's experience on outcomes of endovascular thrombectomy in acute ischemic stroke: results from the MR CLEAN Registry

Autor: Susanne G H Olthuis, Sanne J den Hartog, Sander M J van Kuijk, Julie Staals, Faysal Benali, Christiaan van der Leij, Debbie Beumer, Geert J Lycklama à Nijeholt, Maarten Uyttenboogaart, Jasper M Martens, Pieter-Jan van Doormaal, Jan Albert Vos, Bart J Emmer, Diederik W J Dippel, Wim H van Zwam, Robert J van Oostenbrugge, Inger R de Ridder

Publikováno v: Journal of Neurointerventional Surgery, 15(2), 113-119. BMJ Publishing Group
Journal of NeuroInterventional Surgery, 15(2), 113-119. BMJ Publishing Group
Journal of neurointerventional surgery. BMJ Publishing Group

BackgroundThe relationship between the interventionist’s experience and outcomes of endovascular thrombectomy (EVT) for acute ischemic stroke of the anterior circulation, is unclear.ObjectiveTo assess the effect of the interventionist’s level of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46e2aec14fd63d7bf2b3e59df4ff939f
https://doi.org/10.1136/neurintsurg-2021-018295